首页> 外文期刊>Journal of proteomics >Elevated urine histone 4 levels in women with ovarian endometriosis revealed by discovery and parallel reaction monitoring proteomics
【24h】

Elevated urine histone 4 levels in women with ovarian endometriosis revealed by discovery and parallel reaction monitoring proteomics

机译:通过发现和平行反应监测蛋白质组学的卵巢子宫内膜异位症患有卵巢子宫内膜异位症的尿液组蛋白4水平

获取原文
获取原文并翻译 | 示例
           

摘要

Endometriosis is a common gynecologic disorder and due to a lack of non-invasive detection methods, it can take up to 12 years before an affected woman obtains a diagnosis and receives appropriate treatment. Therefore, the identification of a specific biomarker that can be detected quickly and non-invasively is urgently needed. In this study, the urine proteome, a potentially rich source of biomarkers, is examined in patients with or without endometriosis in an attempt to identify novel protein biomarkers that can be used to diagnose endometriosis. This study is the first to combine tandem mass tags and parallel reaction monitoring approaches to aid in identifying and validating urine biomarkers for endometriosis. The findings presented herein support previous conclusions that endometriosis is a chronic inflammatory disease. Additionally, Histone 4 was identified as a potential biomarker and/or therapeutic target for endometriosis. At a cutoff of 14.2, the area under the curve for H4 was 0.848, with a sensitivity of 70% and specificity of 80%. Moreover, to our knowledge, this is the first study to observe an elevated histone level in body fluids obtained from endometriosis patients. While this study provides a good foundation, further studies are required to further validate the results presented.
机译:子宫内膜异位症是一种常见的妇科疾病,由于缺乏非侵入性的检测方法,可能需要在受影响的女性获得诊断和接受适当治疗之前需要12年。因此,迫切需要可以快速和非侵入地检测的特定生物标志物的鉴定。在这项研究中,尿素蛋白质组是一种潜在富含生物标志物的潜在富含的生物标志物,用于试图鉴定可用于诊断子宫内膜异位症的新型蛋白质生物标志物。本研究是第一个结合串联质量标签和平行反应监测方法,以帮助鉴定和验证尿生物标志物进行子宫内膜异位症。本文提出的结果支持先前结论,内膜异位症是一种慢性炎症疾病。另外,组蛋白4被鉴定为子宫内膜异位症的潜在生物标志物和/或治疗靶标。在14.2的截止值下,H4曲线下的面积为0.848,灵敏度为70%,特异性为80%。此外,对于我们的知识,这是第一次研究从子宫内膜异位症患者获得的体液中的升高的组蛋白水平。虽然本研究提供了良好的基础,但需要进一步的研究来进一步验证所呈现的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号